Christopher Booth, PhD
Dana-Farber Cancer Institute
I performed my undergraduate studies at the University of Cambridge, UK, graduating in 2012 with a BA and MSci in Natural Sciences (Biochemistry). For my PhD I joined the lab of Adam Mead at the Weatherall Institute of Molecular Medicine in Oxford, UK, where I worked on the role of the transcriptional regulators EZH2 and RUNX1 in hematological disease. My PhD work was published in Cancer Cell (Booth et al., 2018), and I was awarded the institute’s Ita Askonas Prize in 2016 and Radcliffe Department of Medicine Graduate Prize in 2019. I graduated with a DPhil in Medical Sciences from the University of Oxford in 2018. I then moved to Boston, MA to join the lab of Andy Lane at the Dana-Farber Cancer Institute, where I have been investigating fusions of the MYB transcription factor in Blastic Plasmacytoid Dendritic Cell Neoplasm. To support this work, I was awarded a 2-year Postdoctoral Fellowship from the European Molecular Biology Organization in 2020.